When administered, B12 injections allow the vitamin to enter the body efficiently and support the bodys natural processes that rely on adequate B12 levels
Potential Positives Teva Pharmaceuticals has achieved FDA approval and launched the first-ever generic GLP-1 product indicated for weight loss, enhancing market presence in a growing therapeutic category
In a study of adipose mass, growth therapy treatment for 26 weeks resulted in: Subcutaneous fat mass decreased by 13% Intra-abdominal fat mass reduced by 30% Lean body mass increased by 3-11% Aerobic function improved by 11-19% Muscle strength increased by 7-19% These changes continued during one year of treatment resulting in a 22% reduction in overall fat mass and a 61% reduction in belly fat
Nothing herein constitutes medical, scientific, legal, or professional advice
Although homocysteine levels increase with age, a reduction in the cardiovascular risk associated with hyperhomocysteinemia also has been reported in subjects older than 45 years (Reis et al, 1995)